Work Packages
The work plan is structured in ten work packages, reflecting development (WP2-5) and validation (WP6-8) activities as well as general management of the project (WP1), its results (WP9) and impact (WP10). Each work package has a lead partner, with support from several partners.
WP1 covers overall management and coordination of the project which includes data management and ethics. The work package is led by Medical University of Graz.
WP2 deals with the development of a generic electrochemical platform for the simultaneous, quantitative electrochemical detection of multiple biomarkers. The work package is led by Ghent University.
The objective of WP3 is to develop a generic platform for the multiplexed simultaneous detection of single nucleotide polymorphisms in genomic DNA extracted from a finger prick blood sample. Universitat Rovira I Virgili leads this work package.
WP4 is concerned with the development of microfluidic sampling and sample preparation technologies for handling and preparing finger prick
blood in a microfluidic manifold. The WP is led by Fraunhofer IMM.
In WP5 the adaption and development of the PoC tool with integrated potentiostat takes place. The work package is led by Labman Automation.
The objective of WP6 is the clinical validation of the PoC tool (POCT-Cardio-Val trial) in accordance with current EU standards and ethical matters. This WP is led by Tehran University of Medical Sciences.
WP7 undertakes the preparation of the multicentre clinical trial (BIO-RISK-EVENT trial) and the provision of relevant documents and organisational needs. The WP is led by Medical University of Graz.
WP8 will ensure initiation, execution and validation of the multicentre clinical trial (BIO-RISK-EVENT trial), and coordination across multicentre sites. The work package is led by Medical University of Graz.
The objective of WP9 is to implement an effective clinical data management and coordinate an AI-based data analysis of the clinical data generated by the multicentre clinical trial (BIO-RISK-EVENT trial) and retrospective sample analysis. The WP is led by Medical University of Graz.
The objective of WP10 is to ensure that the project has the greatest impact possible by support of communication, dissemination and exploitation. The work package is led by Ghent University.
